What is Intuitive Surgical's revenue performance for the quarter?

For the three months ended June 30, 2002, Intuitive Surgical reported sales of $19.4 million, a 52% increase from $12.7 million in the same period of 2001. This growth was primarily driven by an increase in da Vinci Surgical System placements and a significant rise in recurring revenue from instruments, accessories, and service, which grew by 111%.

Is the company profitable, and what is its net loss trend?

Intuitive Surgical is not yet profitable and reported a net loss of $3.7 million for the three months ended June 30, 2002. This represents an improvement compared to a net loss of $4.2 million in the prior year's second quarter. The company continues to invest heavily in research and development and selling, general, and administrative expenses.

What is the company's cash position and liquidity outlook?

The company's cash and cash equivalents increased to $23.9 million as of June 30, 2002, up from $10.5 million at the end of 2001. Net cash provided by investing activities was $20.1 million for the first six months of 2002. Management believes its current cash and short-term investments, along with anticipated revenues, will be sufficient to fund operations through at least 2003.

What are the major risks or legal challenges facing the company?

Intuitive Surgical is involved in significant intellectual property litigation with Computer Motion, Inc. and Brookhill-Wilk 1, LLC. These lawsuits concern patent infringements related to robotic surgery technology and could result in significant damages, require costly licensing agreements, or prevent the sale of products if the company does not prevail. The company also faces risks related to market acceptance, regulatory approvals, competition, and reliance on key suppliers.

ISRG 10-Q Quarterly Report Q2 FY2002 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. reported for the period ending June 29, 2002, a significant increase in sales, demonstrating strong top-line growth driven by higher da Vinci Surgical System placements and increased recurring revenue from instruments, accessories, and service. While the company continues to experience net losses, the rate of loss has improved compared to the prior year's periods, suggesting progress towards operational efficiency. Despite the revenue growth, the company faces substantial research and development and selling, general, and administrative expenses, which are indicative of ongoing investment in product development and expansion of sales and support infrastructure. The company's cash position has strengthened due to operating and investing activities, and management believes current resources are sufficient to fund operations through at least 2003. Investors should note the significant ongoing litigation with Computer Motion and Brookhill-Wilk 1, LLC, which presents ongoing risks and potential financial impacts.

Key Highlights

1Sales increased by 52% to $19.4 million for the three months ended June 30, 2002, compared to $12.7 million in the prior year period.
2Recurring revenue (instruments, accessories, and service) more than doubled, growing 111% to $3.8 million in the second quarter of 2002.
3The company shipped 16 da Vinci Surgical Systems in Q2 2002, up from 12 in Q2 2001, and cumulative shipments reached 118 by June 30, 2002.
4Gross profit margin improved to 52% in Q2 2002 from 48% in Q2 2001, attributed to sales growth, higher ASPs, and manufacturing efficiencies.
5Net loss narrowed to $3.7 million ($0.10 per share) for Q2 2002, an improvement from a $4.2 million loss ($0.12 per share) in Q2 2001.
6Cash and cash equivalents increased significantly to $23.9 million as of June 30, 2002, compared to $10.5 million at the end of 2001.
7Significant ongoing litigation with Computer Motion and Brookhill-Wilk 1, LLC poses potential risks to product sales and financial performance.

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2002

Summary

Key Highlights

Frequently Asked Questions